Phase 2 Open-label, Single-arm, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Camostat Mesylate in Patients with Protein-losing Enteropathy after Fontan Operation-Preliminary Outcome

被引：0
|
作者：
Park, Woo Young
Kim, Gi Beom
Lee, Sang
Baek, Jae Suk
Kim, Soo Jin
Jung, Jowon
Hyun, Myung Chul
Lim, Young Tae
Lee, Hyoung-Doo
Ko, Hoon
Lee, Joowon
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
Camostat mesylate; protein-losing enteropathy; Fontan operation;
D O I：
10.1161/circ.150.suppl_1.4144560
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4144560
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Safety and efficacy of hetrombopag in patients with chronic immune thrombocytopenia: a single-arm, open-label, multi-center phase 1 study
    Mei, Heng
    Chen, Xiequn
    Zhou, Jianfeng
    Luo, Jianmin
    Shi, Qingzhi
    Liu, Jing
    Wu, Depei
    Chen, Guoan
    Tai, Yanfei
    Xiong, Junye
    Zou, Jianjun
    Hu, Yu
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (02)
  • [2] Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
    Manuel Santamaria
    Olaf Neth
    Jo A. Douglass
    Gergely Krivan
    Robin Kobbe
    Ewa Bernatowska
    Sofia Grigoriadou
    Claire Bethune
    Anita Chandra
    Gerd Horneff
    Michael Borte
    Anja Sonnenschein
    Pavlina Kralickova
    Silvia Sánchez Ramón
    Daman D. Langguth
    Luis Ignacio Gonzalez‑Granado
    Laia Alsina
    Montse Querolt
    Rhonda Griffin
    Carrie Hames
    Elsa Mondou
    Jeffrey Price
    Ana Sanz
    Jiang Lin
    Journal of Clinical Immunology, 2022, 42 : 512 - 513
  • [3] Prospective, Non-Randomized, Open-Label, Single-Arm, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Immunoglobulin 10% Formulation in Patients with Immune Thrombocytopenia (ITP)
    Bang, Soo-Mee
    Mun, Yeung-Chul
    Shin, Ho-Jin
    Jung, Chul Won
    Bae, Sung Hwa
    Sohn, Sang Kyun
    Kim, Kyoung Ha
    Kim, Hawk
    Yhim, Ho-Young
    Hong, Junshik
    Kim, Hye Joo
    Lee, Jae-hoon
    Oh, Doyeun
    BLOOD, 2016, 128 (22)
  • [4] High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study
    Li, Jun
    Han, Qi
    Huang, Yanqing
    Wei, Yanhui
    Zi, Jie
    Zhao, Lidong
    Cai, Zhimei
    Lu, Xuzhang
    Xiao, Rong
    Zhang, Yanming
    Yang, Xiaotian
    Xu, Hao
    Sun, Naitong
    Zhuang, Wanchuan
    Wu, Zhengdong
    Xia, Yuan
    Xu, Yanli
    He, Bin
    Zhu, Wei
    Min, Fengling
    Chen, Yongchun
    Ding, Banghe
    Shi, Peimin
    Xie, Jing
    Tang, Hua
    Liu, Zefa
    Li, Bingzong
    Sun, Yu
    Qiu, Hongxia
    Duan, Limin
    Dovat, Elanora
    Song, Chunhua
    SzeKely, Laszlo
    Dovat, Sinisa
    Ge, Zheng
    BLOOD CANCER JOURNAL, 2022, 12 (10)
  • [5] High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study
    Jun Li
    Qi Han
    Yanqing Huang
    Yanhui Wei
    Jie Zi
    Lidong Zhao
    Zhimei Cai
    Xuzhang Lu
    Rong Xiao
    Yanming Zhang
    Xiaotian Yang
    Hao Xu
    Naitong Sun
    Wanchuan Zhuang
    Zhengdong Wu
    Yuan Xia
    Yanli Xu
    Bin He
    Wei Zhu
    Fengling Min
    Yongchun Chen
    Banghe Ding
    Peimin Shi
    Jing Xie
    Hua Tang
    Zefa Liu
    Bingzong Li
    Yu Sun
    Hongxia Qiu
    Limin Duan
    Elanora Dovat
    Chunhua Song
    Laszlo SzeKely
    Sinisa Dovat
    Zheng Ge
    Blood Cancer Journal, 12
  • [6] A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)
    Zhang, Fengkui
    Peng, Guangxin
    He, Guangsheng
    Chang, Hong
    Gao, Sujun
    Liu, Xinjian
    Chen, Tong
    Li, Pei
    Han, Bing
    Miao, Miao
    Ge, Zheng
    Ge, Xiaoyan
    Li, Fei
    Li, Yingmei
    Wang, Shunqing
    Wang, Yi
    Shen, Yaqi
    Tai, Yanfei
    Zhang, Tao
    Zhu, Bo
    Zou, Jianjun
    BLOOD, 2020, 136
  • [7] Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care
    Bapsy, Poonamalle Parthasarathy
    Sharan, Bandana
    Kumar, Chaitanya
    Das, Rajeev Patrick
    Rangarajan, Bharath
    Jain, Minish
    Attili, Venkata Sathya Suresh
    Subramanian, Sundaram
    Aggarwal, Shyam
    Srivastava, Mala
    Vaid, Ashok
    CYTOTHERAPY, 2014, 16 (02) : 234 - 244
  • [8] A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the Safety and Efficacy of Abcertin® in Patients with Type 1 Gaucher Disease
    Choi, Jin-Ho
    Lee, Beom Hee
    Ko, Jung Min
    Sohn, Young Bae
    Lee, Jin-Sung
    Kim, Gu-Hwan
    Heo, Sun Hee
    Park, June-Young
    Kim, Yoo-Mi
    Kim, Ja-Hye
    Yoo, Han-Wook
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (04) : 378 - 384
  • [9] Protocol to evaluate the efficacy and safety of tolvaptan in patients with refractory ascites after liver resection: an open-label, single-arm phase I/II
    Namba, Yosuke
    Kobayashi, Tsuyoshi
    Kuroda, Shintaro
    Hashimoto, Masakazu
    Takei, Daisuke
    Fukuhara, Sotaro
    Oshita, Ko
    Matsubara, Keiso
    Honmyo, Naruhiko
    Nakano, Ryosuke
    Sakai, Hiroshi
    Tahara, Hiroyuki
    Ohira, Masahiro
    Ide, Kentaro
    Ohdan, Hideki
    INTERNATIONAL JOURNAL OF SURGERY PROTOCOLS, 2024, 28 (01): : 1 - 5
  • [10] Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial
    Koonrungsesomboon, Nut
    Ngamphaiboon, Nuttapong
    Townamchai, Natavudh
    Teeyakasem, Pimpisa
    Charoentum, Chaiyut
    Charoenkwan, Pimlak
    Natesirinilkul, Rungrote
    Sathitsamitphong, Lalita
    Ativitavas, Touch
    Chaiyawat, Parunya
    Klangjorhor, Jeerawan
    Hongeng, Suradej
    Pruksakorn, Dumnoensun
    BMC CANCER, 2020, 20 (01)
12345